$DUET
DUET Acquisition Corp Stock $duet

$duet Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224035069 Filed on September 05, 2024

Income Statement

Concept	2024 Q2	2023 Q4
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$32.64K	$40.00K
YoY Change	-34.72%	-78.97%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$97.73K	$720.5K
YoY Change	-90.85%	156.79%
Operating Profit	-$97.73K
YoY Change	-90.85%
Interest Expense	$190.4K	$713.6K
YoY Change	-77.63%	63.63%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$92.68K	-$6.900K
YoY Change	-142.74%	-104.44%
Income Tax	$89.98K	-$224.2K
% Of Pretax Income	97.09%
Net Earnings	$2.697K	$217.3K
YoY Change	-100.7%	-395.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.59M	$87.13K
YoY Change	22558.02%	221.87%
Cash & Equivalents	$3.055K	$87.13K
Short-Term Investments	$14.59M	$13.98M
Other Short-Term Assets	$500.00
YoY Change
Inventory
Prepaid Expenses	$500.00
Receivables
Other Receivables
Total Short-Term Assets	$3.555K	$87.13K
YoY Change	-94.48%	221.92%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.59M	$13.98M
YoY Change	-72.51%	-84.22%
Total Long-Term Assets	$14.59M	$13.98M
YoY Change	-72.51%	-84.22%
TOTAL ASSETS
Total Short-Term Assets	$3.555K	$87.13K
Total Long-Term Assets	$14.59M	$13.98M
Total Assets	$14.59M	$14.07M
YoY Change	-72.54%	-84.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$161.7K	$168.8K
YoY Change	-4.15%	-7.54%
Accrued Expenses	$2.010M	$2.700M
YoY Change	88.55%	10700.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.674M	$2.333M
YoY Change	158.97%	2232.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.677M	$5.287M
YoY Change	121.32%	627.36%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.588M	$2.588M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$2.588M	$2.588M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.677M	$5.287M
Total Long-Term Liabilities	$2.588M	$2.588M
Total Liabilities	$8.264M	$7.874M
YoY Change	60.39%	137.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.116M	-$6.834M
YoY Change	152.15%	205.2%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.115M	$6.192M
YoY Change
Total Liabilities & Shareholders Equity	$14.59M	$14.07M
YoY Change	-72.54%	-84.13%

Cashflow Statement

Concept	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	$2.697K	$217.3K
YoY Change	-100.7%	-395.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$35.04K	-$132.4K
YoY Change	-76.79%	164.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$120.0K	$37.74M
YoY Change	-100.33%
Cash From Investing Activities	-$120.0K	$37.74M
YoY Change	-100.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$38.17M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	141.4K	-37.70M
YoY Change	-100.39%	-75490.78%
NET CHANGE
Cash From Operating Activities	-35.04K	-132.4K
Cash From Investing Activities	-120.0K	37.74M
Cash From Financing Activities	141.4K	-37.70M
Net Change In Cash	-13.60K	-89.93K
YoY Change	-90.52%	89830.0%
FREE CASH FLOW
Cash From Operating Activities	-$35.04K	-$132.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001890671
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2744116
	dei	Entity Address Address Line1 EntityAddressAddressLine1	V03-11-02, Designer Office
	dei	Entity Address Address Line2 EntityAddressAddressLine2	V03, Lingkaran SV
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Sunway Velocity
	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
	dei	Entity Address Country EntityAddressCountry	MY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55100
	dei	City Area Code CityAreaCode	(914)
	dei	Local Phone Number LocalPhoneNumber	316-4805
CY2024Q2	us-gaap	Cash Cash	3055	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1283336	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	343765	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	2697	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	2697	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	DUET	Proceeds From Cash Withdrawn From Trust Account In Redemption ProceedsFromCashWithdrawnFromTrustAccountInRedemption		usd
	DUET	Proceeds From Extension Loan ProceedsFromExtensionLoan		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
	us-gaap	Temporary Equity Accretion Of Interest TemporaryEquityAccretionOfInterest		usd
CY2023Q2	DUET	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue		usd
	DUET	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue		usd
CY2024Q2	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees		usd
CY2023Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense		usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41237
	dei	Entity Registrant Name EntityRegistrantName	DUET Acquisition Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	us-gaap	Cash Cash	87134	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	500	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3555	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	87134	usd
CY2024Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	14588710	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	13979449	usd
CY2024Q2	us-gaap	Assets Assets	14592265	usd
CY2023Q4	us-gaap	Assets Assets	14066583	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2010264	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1914504	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	161747	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	168747	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2009	usd
CY2024Q2	DUET	Franchise Tax Payable FranchiseTaxPayable	16463	usd
CY2023Q4	DUET	Franchise Tax Payable FranchiseTaxPayable	19713	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	28966	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	63662	usd
CY2024Q2	DUET	Excise Tax Payable Current ExciseTaxPayableCurrent	785497	usd
CY2023Q4	DUET	Excise Tax Payable Current ExciseTaxPayableCurrent	785497	usd
CY2024Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1370000	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1090000	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	1303842	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1242500	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5676779	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5286632	usd
CY2024Q2	DUET	Deferred Underwriter Commission DeferredUnderwriterCommission	2587500	usd
CY2023Q4	DUET	Deferred Underwriter Commission DeferredUnderwriterCommission	2587500	usd
CY2024Q2	us-gaap	Liabilities Liabilities	8264279	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7874132	usd
CY2024Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1283336	shares
CY2024Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1283336	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1283336	shares
CY2024Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.25
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	14443281	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	13025860	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8115559	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6833673	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-8115295	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6833409	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14592265	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14066583	usd
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	65085	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1017814	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	348422	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1452332	usd
CY2024Q2	DUET	Franchise Tax Expenses FranchiseTaxExpenses	32640	usd
CY2023Q2	DUET	Franchise Tax Expenses FranchiseTaxExpenses	50000	usd
	DUET	Franchise Tax Expenses FranchiseTaxExpenses	65280	usd
	DUET	Franchise Tax Expenses FranchiseTaxExpenses	100000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-97725	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1067814	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-413702	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1552332	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	190400	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	850973	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	683202	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1736977	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	92675	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-216841	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	269500	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	184644	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89978	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	168204	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	133966	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-385045	usd
	us-gaap	Net Income Loss NetIncomeLoss	135534	usd
	us-gaap	Net Income Loss NetIncomeLoss	-159121	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6833409	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	132838	usd
CY2024Q1	DUET	Stock Issued During Period Value Remeasurement Of Class Common Stock Subject To Redemption StockIssuedDuringPeriodValueRemeasurementOfClassCommonStockSubjectToRedemption	-1229640	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-7930211	usd
CY2024Q2	DUET	Stock Issued During Period Value Remeasurement Of Class Common Stock Subject To Redemption StockIssuedDuringPeriodValueRemeasurementOfClassCommonStockSubjectToRedemption	-187781	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-8115295	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2238851	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	225923	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-2012928	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-2012928	usd
CY2023Q2	DUET	Stock Issued During Period Value Remeasurement Of Class Common Stock Subject To Redemption StockIssuedDuringPeriodValueRemeasurementOfClassCommonStockSubjectToRedemption	-820319	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-385045	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-385045	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3218292	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3218292	usd
	us-gaap	Net Income Loss NetIncomeLoss	135534	usd
	us-gaap	Net Income Loss NetIncomeLoss	-159121	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	683202	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1736977	usd
	DUET	Interest Withdrawn From Trust Account InterestWithdrawnFromTrustAccount	273942	usd
	DUET	Interest Withdrawn From Trust Account InterestWithdrawnFromTrustAccount	620245	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	500	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-13773	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	95760	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1041184	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2009	usd
	DUET	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	3250	usd
	DUET	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	180493	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-34696	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	58765	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-225421	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-370170	usd
	DUET	Proceeds From Cash Withdrawn From Trust Account In Redemption ProceedsFromCashWithdrawnFromTrustAccountInRedemption	36347008	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	200000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	525000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35822008	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	231342	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	932500	usd
	DUET	Proceeds From Extension Loan ProceedsFromExtensionLoan	120000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	36347008	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	10000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	341342	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35414508	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-84079	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37330	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	87134	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27066	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3055	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64396	usd
	DUET	Remeasurement Of Class Common Stock Subject To Redemption RemeasurementOfClassCommonStockSubjectToRedemption	-1417421	usd
	DUET	Remeasurement Of Class Common Stock Subject To Redemption RemeasurementOfClassCommonStockSubjectToRedemption	820319	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zmBu2EhcaQYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_82E_zlYzPi6Xzv5b">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DUET Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on September 20, 2021. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024, the Company had not commenced any operations. All activity for the period from September 20, 2021 (inception) through June 30, 2024, relates to the Company’s formation, the initial public offering and preparation for a business combination described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering (as defined below). The Company has selected December 31 as its fiscal year end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sponsor is DUET Partners LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on January 19, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2022, the Company consummated its Initial Public Offering of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zicelFMS5jHc" title="Number of stock units issued">7,500,000</span> units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zIm2dIQgSF1d" title="Number of units issued, at par value">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zwMmwJc2BmJc" title="Proceeds from initial public offering">75,000,000</span>, and incurring offering costs of $<span style="background-color: white"><span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zIcvs7oaMOmd" title="Offering costs">5,161,516</span></span>, of which $<span id="xdx_90C_ecustom--DeferredUnderwriterCommission_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zurP6vGVjoTa" title="Deferred underwriting commissions">2,250,500</span> was for deferred underwriting commissions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the consummation of the closing of the Offering, the Company consummated the private placement of an aggregate of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_z7DEqWFWEvv2" title="Number of stock units issued">356,250</span> units (the “Private Placement Units”) to DUET Partners LLC, the sponsor of the Company (the “Sponsor”), at a price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zpw0nhh3CjQg" title="Number of units issued, at par value">10.00</span> per Private Placement Unit, generating total gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zvWSVDiEL4Ik" title="Proceeds from private placement">3,562,500</span> (the “Private Placement”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequently, on January 24, 2022, the Company consummated the closing of the sale of <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zPRrv9hCRAw9" title="Number of stock units issued">1,125,000</span> additional units at a price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zks6ykkWYYe1" title="Number of units issued, at par value">10</span> per unit (the “Units”) upon receiving notice of the underwriters’ election to fully exercise their overallotment option (“Overallotment Units”), generating additional gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ze17D8qOY9tf" title="Proceeds from sale of units">11,250,000</span> and incurred additional offering costs of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zkpyWJz4JEeg" title="Offering costs">506,250</span>, of which $<span id="xdx_905_ecustom--DeferredUnderwriterCommission_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zCYhBsqSgSGh" title="Deferred underwriting commissions">337,500</span> are for deferred underwriting commissions. <span id="xdx_903_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zbxCrtcD1Nyc" title="Units description">Each Unit consists of one share of Class A common stock of the Company, par value $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zFTBK2QXuNdf" title="Common stock, par value">0.0001</span> per share (“Class A Common Stock”), one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zcJLEnag29f5" title="Shares issued, per share">11.50</span> per share</span>, subject to adjustment, pursuant to the Company’s registration statement on Form S-1 (File No. 333-261494).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the exercise of the overallotment option, the Company consummated the Private Placement of an additional <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementOneMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zZS4IxNqUhTk" title="Number of stock units issued">33,750</span> Private Placement Units to DUET Partners LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementOneMember__dei--LegalEntityAxis__custom--DuetPartnersLLCMember_zSpu5Fy1Txr6" title="Proceeds from sale of private placement units">337,500</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A total of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220123__20220124_zYWFIO66AcY1" title="Proceeds from offering and private placements">87,543,750</span>, comprised of the proceeds from the Offering and the proceeds of private placements that closed on January 20, 2022 and January 24, 2022, net of the underwriting commissions, discounts, and offering expenses, was deposited in a trust account (“Trust Account”) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction costs of the Initial Public Offering with the exercise of the overallotment option amounted to $<span id="xdx_908_eus-gaap--PaymentOfFinancingAndStockIssuanceCosts_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6kyBwx7SHEe">4,374,016</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> consisting of $<span id="xdx_904_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrQRWShytrR1">1,293,750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of cash underwriting fees, $<span id="xdx_904_ecustom--DeferredUnderwritingFees_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znKoELyHq3X7" title="Deferred underwriting fees">2,587,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of deferred underwriting fees and $<span id="xdx_903_eus-gaap--OtherExpenses_c20220123__20220124__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2nv7YsbjhS7">492,766 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of other costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the closing of the Initial Public Offering $<span id="xdx_903_eus-gaap--AssetsHeldInTrust_iI_c20220124_zbbIkxovqgS">818,211</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of cash was held outside of the Trust Account available for working capital purposes. As of June 30, 2024, we have available to us $<span id="xdx_903_eus-gaap--Cash_iI_c20240630_zzGxu3WDZ1q7">3,055 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of cash on our condensed balance sheet and a working capital deficit of $<span id="xdx_900_ecustom--WorkingCapital_iI_c20240630_zd8t7E89emRi" title="Working capital">5,673,224</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20240630__us-gaap--BusinessAcquisitionAxis__custom--DuetPartnersLLCMember__srt--RangeAxis__srt--MinimumMember_zNQ08RnWTzMj" title="Business acquistion, ownership interest percentage">80</span>% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20240630__us-gaap--BusinessAcquisitionAxis__custom--DuetPartnersLLCMember_zudh8JOXumzc" title="Business acquistion, ownership interest percentage">50</span>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $<span id="xdx_903_eus-gaap--IntangibleAssetsNetIncludingGoodwill_iI_c20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zFVbOoE1tn64" title="Intangible assets net">5,000,001</span> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will have until 24 months (subject to a three month extension of time, as set forth in the Company’s registration statement) from the closing of the Public Offering to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem <span id="xdx_905_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20240101__20240630_zBHbp6jsVLMc" title="Redemption percentage">100</span>% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit of $<span id="xdx_90D_ecustom--SharePriceAvailableForDistributionForPublicOfferingPricePerUnit_iI_c20240630_z6xSFFMfWigh" title="Share price available for distribution for public offering price per unit">10.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 19, 2023, the Company held a virtual special meeting of its stockholders (the “Special Meeting”). At the Special Meeting, the stockholders of the Company approved the proposal (the “Extension Amendment Proposal”) to amend the Company’s Amended and Restated Certificate of Incorporation to extend the date by which the Company must (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination involving the Company and one or more businesses, which we refer to as a “business combination,” (ii) cease its operations if it fails to complete such business combination, and (iii) redeem or repurchase <span id="xdx_90E_ecustom--PercentageOfRepurchaseOfEquity_pid_dp_c20230419__20230419__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zU4G9Mp6zcl6" title="Percentage of repurchase of equity">100</span>% of the Company’s Class A Common Stock included as part of the units sold in the Initial Public Offering from April 24, 2023 to January 24, 2024, or such earlier date as determined by the board of directors, pursuant to nine one-month extensions, provided that (i) the Sponsor or its affiliates or permitted designees will deposit into the Trust Account the lesser of (x) $<span id="xdx_90F_eus-gaap--Deposits_iI_c20230419__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_z9bChVotFQj4" title="Deposits">175,000</span> or (y) $<span id="xdx_904_eus-gaap--SharePrice_iI_c20230419__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zpyKWejBkp04" title="Share price">0.055</span> per share for each Public Share that was not redeemed in connection with the Special Meeting for each such one-month extension, unless the closing of the Company’s initial Business Combination shall have occurred, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination and (ii) the procedures relating to any such extension, as set forth in the Trust Agreement, shall have been complied with.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 18, 2023, the Company held a virtual special meeting of its stockholders (the “Special Meeting”). At the Special Meeting, the stockholders of the Company approved the proposal (the “Extension Amendment Proposal”) to amend the Company’s Amended and Restated Certificate of Incorporation to extend the date by which the Company must (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination involving the Company and one or more businesses, which we refer to as a “business combination,” (ii) cease its operations if it fails to complete such business combination, and (iii) redeem or repurchase <span id="xdx_901_ecustom--PercentageOfRepurchaseOfEquity_pid_dp_c20231218__20231218__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_z3Z99Q26adVa" title="Percentage of repurchase of equity">100</span>% of the Company’s Class A common stock (the “Class A Common Stock”) included as part of the units sold in the Company’s initial public offering that was consummated on January 24, 2022, which we refer to as the “IPO,” from January 24, 2024 (the “Termination Date”) to January 24, 2025 or such earlier date as determined by the board of directors, pursuant to twelve one-month extensions, which we refer to as the “Extension,” and such later date, the “Extended Date,” provided that (i) the Sponsor, or its affiliates or permitted designees will deposit into the Trust Account the lesser of (x) $<span id="xdx_903_eus-gaap--Deposits_iI_c20231218__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_z85CYsYkuoTb" title="Deposits">40,000</span> or (y) $<span id="xdx_906_eus-gaap--SharePrice_iI_c20231218__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_z6lgkG8lLXP7" title="Share price">0.04</span> per share for each public share that is not redeemed in connection with the Special Meeting for each such one-month extension commencing December 24, 2023 until January 24, 2025 unless the closing of the Company’s initial business combination shall have occurred (the “Extension Payment”) in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination (ii) the procedures relating to any such extension, as set forth in the Trust Agreement, shall have been complied with.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the approval of the Extension Amendment Proposal and the Trust Amendment Proposal at the Special Meeting, holders of <span id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20231218__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbJnwLXfqaC" title="Redemption of shares">3,760,678</span> shares of the Company’s Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of $<span id="xdx_904_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_c20231218__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zK03s1tAoOv8" title="Temporary equity, redemption price per share">10.95</span> per share, for an aggregate of approximately $<span id="xdx_905_eus-gaap--PaymentsForRepurchaseOfEquity_pn5n6_c20231218__20231218__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6aR3ybFe75" title="Shares redeemed value">41.2</span> million. Following the payment of the redemptions, the Trust Account will have a balance of approximately $<span id="xdx_90B_eus-gaap--AssetsHeldInTrust_iI_pn5n6_c20240630_zr3AoNO4wN5k" title="Cash in trust account">14.1</span> million before the Extension Payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 19, 2023, the Company deposited two payments in an aggregate of $<span id="xdx_907_eus-gaap--PaymentsForDeposits_c20231219__20231219__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_znXr63nRFTn2" title="Payments for deposits">80,000</span> (the “Extension Payment”) into the Trust Account, which enables the Company to extend the period of time it has to consummate its initial business combination by two months from December 24, 2023 to <span id="xdx_909_ecustom--BusinessCombinationExtensionDate_dd_c20231219__20231219__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zs4QtGYBtK7e" title="Business combination, extension date">February 24, 2024</span>. On February 16, 2024, the Company caused to be deposited $<span id="xdx_907_eus-gaap--PaymentsForDeposits_c20240216__20240216__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_znjMsMbS5257" title="Payments for deposits">40,000</span> into the Company’s Trust Account, allowing the Company to extend the period of time it has to consummate its initial Business Combination by one month from February 24, 2024 to <span id="xdx_90C_ecustom--BusinessCombinationExtensionDate_dd_c20240216__20240216__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zHpW2O0w7xx4" title="Business combination, extension date">March 24, 2024</span>. On March 19, 2024, the Company caused to be deposited $<span id="xdx_90B_eus-gaap--PaymentsForDeposits_c20240319__20240319__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zuZN3ArQfNs7" title="Payments for deposits">40,000</span> into the Company’s Trust Account, allowing the Company to extend the period of time it has to consummate its initial Business Combination by one month from March 24, 2024 to <span id="xdx_90A_ecustom--BusinessCombinationExtensionDate_dd_c20240319__20240319__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zqxa7fcVUZBj" title="Business combination, extension date">April 24, 2024</span>. On April 24, 2024, the Company caused to be deposited $<span id="xdx_90D_eus-gaap--PaymentsForDeposits_c20240424__20240424__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zSiC9McUeZc6" title="Payments for deposits">40,000</span> into the Company’s trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from April 24, 2024 to <span id="xdx_904_ecustom--BusinessCombinationExtensionDate_dd_c20240424__20240424__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_z4cjW1vONGak" title="Business combination, extension date">May 24, 2024</span>.The foregoing extensions are permitted under the Company’s governing documents. On May 24, 2024, the Company caused to be deposited $<span id="xdx_908_eus-gaap--PaymentsForDeposits_c20240524__20240524__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zd2qkJ2cUn73" title="Payments for deposits">40,000</span> into the Company’s trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from May 24, 2024 to <span id="xdx_904_ecustom--BusinessCombinationExtensionDate_dd_c20240524__20240524__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zjchmMzGBVWf" title="Business combination, extension date">June 24, 2024</span>.The foregoing extensions are permitted under the Company’s governing documents. On June 24, 2024, the Company caused to be deposited $<span id="xdx_909_eus-gaap--PaymentsForDeposits_c20240624__20240624__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zKPBkHBOIoGf" title="Payments for deposits">40,000</span> into the Company’s trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from June 24, 2024 to <span id="xdx_90E_ecustom--BusinessCombinationExtensionDate_dd_c20240624__20240624__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zLdDQ68jO8Th" title="Business combination, extension date">July 24, 2024</span>. On July 23, 2024, the Company caused to be deposited $<span id="xdx_90F_eus-gaap--PaymentsForDeposits_c20240723__20240723__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_zVwQI7jxSJ4k" title="Payments for deposits">40,000</span> into the Company’s trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from July 24, 2024, to <span id="xdx_907_ecustom--BusinessCombinationExtensionDate_dd_c20240723__20240723__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgQTanrA7lae" title="Business combination, extension date">August 24, 2024</span>. On August 22, 2024, the Company caused to be deposited $<span id="xdx_900_eus-gaap--PaymentsForDeposits_c20240822__20240822__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember_z5I9TbZLX0oe" title="Payments for deposits">40,000</span> into the Company’s trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from August 24, 2024 to <span id="xdx_90A_ecustom--BusinessCombinationExtensionDate_dd_c20240822__20240822__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentAndTrustAmendmentMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXjtrj2nMic2" title="Business combination, extension date">September 24, 2024</span>. The foregoing extensions are permitted under the Company’s governing documents. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DuetPartnersLLCMember_z7RZYcuKZhNg" title="Shares issued, price per share">10.15</span> per share (whether or not the underwriters’ over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination of the Merger Agreement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 25, 2022, the Company entered into a definitive Business Combination Agreement and Plan of Merger (the “Merger Agreement”) with Millymont Limited, a private limited company incorporated in Ireland (“Holdco”), Duet Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Holdco, J. Streicher Technical Services, LLC, a Delaware limited liability company, Anteco Systems, S.L., trading as AnyTech365, a company incorporated in Spain and registered at the Commercial Registry of Malaga under reference MA-122108, Miguel Ángel Casales Ruiz and Thomas Marco Balsloev, as the sellers’ representatives, and Lee Keat Hin, as the Company’s representative.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 6, 2023, the Company provided the other parties with written notice of the termination of the Merger Agreement pursuant to Section 11.1 thereof (the “Termination”). No party will be required to pay another party a termination fee as a result of the Termination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The termination of the Merger Agreement also terminates and makes void the Support Agreement, the Non-Competition and Non-Solicitation Agreement, and the Lock-up Agreement (each as defined in the Merger Agreement), each of which were executed concurrently with the Merger Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business Combination Agreement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously disclosed, the Company entered into a binding letter of intent with Fenix 360 Pte. Ltd., a Singapore private company limited by shares (the “Target”), on July 6, 2023, pursuant to which DUET agreed to acquire all of the outstanding equity interests of the Target. On November 28, 2023, DUET and the Target entered into a definitive Business Combination Agreement and Plan of Merger (the “Business Combination Agreement”). DUET and the Target are sometimes referred to this Quarterly Report on Form 10-Q, individually, as a “Party” and, collectively, as the “Parties.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Chairman of the Board of Directors, Larry Gan Nyap Liou, serves as a financial advisor to the Target pursuant to a pre-existing relationship with the Target. Accordingly, Mr. Gan has recused himself, and will continue to recuse himself, from all Board decisions related to the Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Domestication</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to and upon the closing (the “Closing”) of the transactions contemplated in the Business Combination Agreement (collectively, the “Business Combination”), the Company will transfer by way of continuation from the State of Delaware to the Cayman Islands and domesticate (the “Domestication”) as a Cayman Islands exempted company limited by shares in accordance with Section 390 of the Delaware General Corporation Law, as amended, and Part XII of the Cayman Islands Companies Act, as amended (the “Cayman Companies Act”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Domestication, <span id="xdx_906_eus-gaap--ConversionOfStockDescription_c20240101__20240630_zmkriyBwpF1a" title="Domestication, shares conversion description">(a) each share of DUET’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), that is issued and outstanding immediately prior to the Domestication shall become one ordinary share of DUET (the “DUET Ordinary Shares”), (b) each share of DUET’s Class B common stock, par value $0.0001 per share (the “Class B Common Stock”), that is issued and outstanding immediately prior to the Domestication shall become one DUET Ordinary Share, (c) each warrant of DUET that is outstanding immediately prior to the Domestication shall, from and after the Domestication, represent the right to purchase one DUET Ordinary Share at an exercise price of $11.50 per share on the terms</span> and subject to the conditions set forth in the Warrant Agreement, dated January 19, 2022 by and between DUET and Continental Stock Transfer & Trust Company, and (d) the governing documents of DUET shall be amended and restated in the form of the amended and restated memorandum and articles of association of DUET in a form to be mutually agreed between the Parties (the “DUET A&R Charter”), and, as so amended and restated, the DUET A&R Charter will be the memorandum and articles of association of DUET until thereafter amended in accordance with the terms thereof and the Cayman Companies Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Combination</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Business Combination Agreement, as consideration for the Business Combination, the shareholders of the Target (each, a “Target Shareholder” and, together, the “Target Shareholders”) are entitled to receive an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zucUF2MVLmJd" title="Number of shares issued for acquisitions">61,000,000</span> DUET Ordinary Shares, valued at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zjwDytoFCwbc" title="Shares issued, price per share">10.00</span> per share for an aggregate value equal to $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20240101__20240630__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zPA1iryCOGqj" title="Number of shares issued acquisitions, value">610,000,000</span>. Each Target Shareholder will be entitled to receive, in accordance with terms of the Business Combination Agreement, one DUET Ordinary Share for each share of the Target (the “Target Ordinary Shares”) held by such Target Shareholder (the “Exchange Consideration”). As of the Effective Time (as defined in the Business Combination Agreement), each Target Shareholder, upon receiving the Exchange Consideration, shall cease to have any other rights in and to the Target.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the terms and subject to the conditions of the Business Combination Agreement, at or prior to the Closing, each Target Shareholder will deliver to Continental Stock Transfer & Trust Company (the “Exchange Agent”) a share exchange agreement in the form mutually agreed to between the Parties (a “Share Exchange Agreement”) that has been duly executed by that Target Shareholder, surrender any original certificates for the Target Ordinary Shares held by such Target Shareholder, and deliver such other documents reasonably requested by DUET. In exchange, DUET will issue and cause the Exchange Agent to deliver to each Target Shareholder the amount of DUET Ordinary Shares due to such Target Shareholder pursuant to the Business Combination Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Representations and Warranties; Covenants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Business Combination Agreement, the Parties made customary representations and warranties for transactions of this type. The Business Combination Agreement includes certain covenants that are customary for transactions of this type, including obligations of the Parties to use reasonable best efforts to operate their respective businesses in the ordinary course and to refrain from taking certain specified actions without the prior written consent of the applicable party, in each case, subject to certain exceptions and qualifications. The Parties have agreed not to solicit, negotiate, or enter into a competing transaction. Additionally, the Target has agreed to certain other covenants, including to (a) deliver the PCAOB Financials (as defined in the Business Combination Agreement) to DUET no later than December 11, 2023, (b) conclude investigations, examinations and diligence with respect to certain agreed-upon items by December 12, 2023 (the “Due Diligence Period”), and (c) onboard certain employees of one of the Target’s primary software developers. The covenants in the Business Combination Agreement generally will not survive the Closing, subject to certain exceptions, including certain covenants and agreements that by their terms are to be performed in whole or in part after the Closing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reserve Against Certain Liabilities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of the Target Shareholders (the “Legacy Shareholders”) are to deposit with the Escrow Agent at Closing their pro rata portion of an aggregate of <span id="xdx_900_eus-gaap--SharesIssued_iI_c20240630_zc6GFvkqMPn8" title="Deposit of ordinary shares into escrow">4,500,000</span> DUET Ordinary Shares otherwise issuable to the Legacy Shareholders as Exchange Consideration (the “Escrow Shares”). The Escrow Shares are subject to a quarterly release following the Closing and are reserved to cover losses arising out of or in connection with the Target’s rescission plan for tokens that were issued by management of the Target, any pending or threatened legal proceedings required to be disclosed by the Target, and any other matters mutually agreed upon by the Parties (collectively, the “Covered Matters”). To the extent the Target incurs losses based on an action against the Target or its affiliates by any third party with respect to the Covered Matters, the Legacy Shareholders consent to and agree to reasonably and promptly allow the post-Closing company to redeem an aggregate number of Escrow Shares with a value equal to the amount of such loss incurred by the post-Closing company therefrom, with the value of the Escrow Shares to be determined using the 5-Day VWAP of the DUET Ordinary Shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions to Obligations of Both Parties at Closing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligations of the Parties to consummate the Business Combination are subject to the satisfaction of the following conditions, any one or more of which may be waived by in writing by either or both of the Parties: (a) DUET stockholder approval of the Business Combination has been obtained; (b) all of the Target Shareholders have submitted a Share Exchange Agreement and have exchanged all of the Target Ordinary Shares for the DUET Ordinary Shares in accordance with the terms of the Business Combination Agreement no later than the date of the DUET Stockholders’ Meeting (defined below); (c) the Proxy/Registration Statement (as defined below) shall have become effective under the Securities Act of 1933, as amended (the “Securities Act”), and no stop order suspending the effectiveness of the Proxy/Registration Statement shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the U.S. Securities and Exchange Commission (the “SEC”) and not withdrawn; (d) the Nasdaq Stock Market LLC (“Nasdaq”) shall have completed its review of the “Listing of Additional Shares Notification Form” filed by DUET with Nasdaq with respect to the DUET Ordinary Shares to be issued in connection with the Business Combination; (e) no Exchange Objection (as defined in the Business Combination Agreement) shall have been raised, or any such Exchange Objection which has been raised shall have been addressed; (f) no federal, state, provincial, municipal, local or foreign government, governmental authority, taxing, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court or tribunal (“Governmental Authority”) shall have enacted, issued, promulgated, enforced or entered any statute, law, ordinance, rule, order, or regulation (“Law”) that is then in effect and which has the effect of making the Business Combination illegal or which otherwise prevents or prohibits consummation of the Business Combination, other than any such restraint that is immaterial, or for which the relevant Governmental Authority does not have jurisdiction over either of the parties hereto with respect to the Business Combination; and (g) all Closing deliverables required under the Business Combination Agreement have been provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions to Obligations of DUET at Closing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Business Combination Agreement, the obligations of DUET to consummate, or cause to be consummated, the Business Combination are subject to the satisfaction of the following additional conditions, any one or more of which may be waived in writing by DUET: (a)(i) the representations and warranties of the Target regarding the capitalization of the Target are true and correct in all respects of the date of the Closing except with respect to such representations and warranties speaking to an earlier date, which shall be true and correct at and as of such date, subject to changes made to the Business Combination Agreement, (ii) the Target’s Fundamental Representations (as defined in the Business Combination Agreement) other than those regarding the capitalization of the Target shall be true and correct as of the date of the Closing, subject to certain qualifications and exceptions, and (iii) each of the representations and warranties of the Target other than the Target’s Fundamental Representations shall be true and correct as of the date of the Closing, subject to certain qualifications and exceptions; (b) each of the covenants of the Target to be performed as of or prior to the Closing shall have been performed in all material respects; (c) there shall not have occurred a Company Material Adverse Effect (as defined in the Business Combination Agreement); (d) each of the Restrictive Covenant Agreements (as defined in the Business Combination Agreement) with each of the Key Executives (as defined in the Business Combination Agreement) shall be in full force and effect at Closing; (e) the Target’s unaudited consolidated statement of financial positions and consolidated statements of comprehensive income, changes in equity and cash flows of the Target and its Subsidiaries as of and for the nine-month period ended September 30, 2023, which comply with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant shall have been provided; and (f) all closing deliveries required by the Business Combination Agreement shall have been delivered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions to Obligations of the Target at Closing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The obligation of the Target to consummate is subject to the satisfaction of the following additional conditions, any one or more of which may be waived in writing by the Target: (a) subject to certain qualifications and exceptions in each: (i) the representations and warranties of DUET regarding the capitalization of DUET shall be true and correct as of the Closing, (ii) DUET’s Fundamental Representations (as defined in the Business Combination Agreement) other than those regarding the capitalization of DUET shall be materially true and correct as of date of the Closing, subject to certain exceptions, and (iii) each of the representations and warranties of DUET contained in the Business Combination Agreement other than those regarding organization, due authorization, absence of changes, capitalization, and brokers’ fees shall be true and correct as of Closing; (b) the Class A Common Stock shall remain listed on the Nasdaq Global Market; and (c) each of the covenants of DUET to be performed as of or prior to the Closing shall have materially been performed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination Agreement may be terminated and the transactions therein may be abandoned: (a) by DUET pursuant to a failure of the Target to deliver timely the PCAOB Financials, or comply with the requests of DUET during the Due Diligence Period; (b) by DUET if the Proxy/Registration Statement is not declared effective or such effectiveness is materially delayed due to any action or omission by the Target; (c) by the Target if DUET is delisted from the Nasdaq Global Market for any reason other than a breach by the Target or Legacy Shareholders of obligations to the Business Combination Agreement; (d) by mutual written consent of all Parties; (e) by DUET or the Target if any Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law or order that is then in effect and which has the effect of making the Business Combination illegal or which otherwise prevents or prohibits their consummation; (f) by DUET if (i) there is a breach of any representation, warranty, covenant or agreement on the part of the Target, such that the conditions obligating DUET to close would not be satisfied, subject to a 30 day cure period for the Target, or (ii) the Closing has not occurred on or before the date on which the DUET charter expires and the Parties agree it shall not be extended (the “Agreement End Date”), unless DUET is in material breach of the Business Combination Agreement; (g) by DUET if the original certificates for the Target duly endorsed for transfer to DUET have not been submitted for exchange along with duly executed Share Exchange Agreements from the Target Shareholders by the date of the DUET Stockholders’ Meeting; (h) by the Target by written notice to DUET if (i) there is any breach of any representation, warranty, covenant or agreement on the part DUET set forth in the Business Combination Agreement, such that the conditions obligating the Target to close would not be satisfied at Closing, subject to a 30 day cure period for DUET upon notice, or (ii) the Closing has not occurred on or before the Agreement End Date, unless the Target is in material breach of the Business Combination Agreement; or (i) if the resolution of outstanding accrued underwriting fees payable to EF Hutton, division of Benchmark Investments LLC, are not resolved, in a manner satisfactory to both DUET and the Target before the Closing. In the event the Business Combination Agreement is terminated pursuant to (a), (b) or (f) above, the Target shall pay DUET $<span id="xdx_907_ecustom--BusinessCombinationTerminationFee_c20240101__20240630_zfMaHOctalB3" title="Business combination termination fee">3,500,000</span> within 10 days of such termination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing description of the Business Combination Agreement does not purport to be complete and is qualified in its entirety by the full text of the Business Combination Agreement, which is filed as Exhibit 2.1 hereto and incorporated herein by reference.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging Growth Company</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern, Liquidity and Capital Resources</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024, the Company had $<span id="xdx_90D_eus-gaap--Cash_iI_c20240630_zxnQanWkAUy5" title="Cash in operating bank">3,055</span> of cash in its operating bank account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $<span id="xdx_901_eus-gaap--ProceedsFromOtherEquity_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DuetPartnersLLCMember_zDmxcpAZvQN9" title="Proceeds from issuance of shares">25,000</span> from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the Sponsor of $<span id="xdx_903_eus-gaap--LoansPayable_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DuetPartnersLLCMember_zkeIQDtz3kUj" title="Loans payable">190,478</span> under the Note (as defined in Note 5). Following the IPO of the Company on January 24, 2022 (as described in Note 1), a total of $<span id="xdx_90B_eus-gaap--ProceedsFromRepaymentsOfDebt_c20220123__20220124_zVaAQYeV2ZO" title="Promissory note repaid">193,535</span> under the promissory note was repaid on January 24, 2022. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of June 30, 2024, there was $<span id="xdx_90E_eus-gaap--LoansPayable_iI_c20240630_z7MSa5TmrtD" title="Working capital loan">1,303,842</span> outstanding under any Working Capital Loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating our initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations. The accompanying unaudited condensed financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	87543750	usd
CY2022Q1	us-gaap	Assets Held In Trust AssetsHeldInTrust	818211	usd
CY2024Q2	us-gaap	Cash Cash	3055	usd
CY2024Q2	DUET	Working Capital WorkingCapital	5673224	usd
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2024Q2	DUET	Share Price Available For Distribution For Public Offering Price Per Unit SharePriceAvailableForDistributionForPublicOfferingPricePerUnit	10.00
CY2024Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	14100000	usd
	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	(a) each share of DUET’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), that is issued and outstanding immediately prior to the Domestication shall become one ordinary share of DUET (the “DUET Ordinary Shares”), (b) each share of DUET’s Class B common stock, par value $0.0001 per share (the “Class B Common Stock”), that is issued and outstanding immediately prior to the Domestication shall become one DUET Ordinary Share, (c) each warrant of DUET that is outstanding immediately prior to the Domestication shall, from and after the Domestication, represent the right to purchase one DUET Ordinary Share at an exercise price of $11.50 per share on the terms
CY2024Q2	us-gaap	Shares Issued SharesIssued	4500000	shares
	DUET	Business Combination Termination Fee BusinessCombinationTerminationFee	3500000	usd
CY2024Q2	us-gaap	Cash Cash	3055	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	193535	usd
CY2024Q2	us-gaap	Loans Payable LoansPayable	1303842	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zTyFMBE0Kjbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zGNpEX9IKjvi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	14588710	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	13979449	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.9709	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.7757	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4971	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.8618	pure
CY2024Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	13025860	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	87543750	usd
CY2023	us-gaap	Temporary Equity Accretion Of Interest TemporaryEquityAccretionOfInterest	78549722	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1417421	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4031832	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	14443281	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	13025860	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	2697	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-385045	usd
	us-gaap	Net Income Loss NetIncomeLoss	135534	usd
	us-gaap	Net Income Loss NetIncomeLoss	-159121	usd
CY2024Q2	DUET	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	-154000	usd
	DUET	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	-154000	usd
CY2024Q2	DUET	Net Loss Including Accretion Of Carrying Value To Redemption Value NetLossIncludingAccretionOfCarryingValueToRedemptionValue	-151303	usd
CY2023Q2	DUET	Net Loss Including Accretion Of Carrying Value To Redemption Value NetLossIncludingAccretionOfCarryingValueToRedemptionValue	-385045	usd
	DUET	Net Loss Including Accretion Of Carrying Value To Redemption Value NetLossIncludingAccretionOfCarryingValueToRedemptionValue	-18466	usd
	DUET	Net Loss Including Accretion Of Carrying Value To Redemption Value NetLossIncludingAccretionOfCarryingValueToRedemptionValue	-159121	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zMUoIG2FSJVl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zBhkMqfLj4eb">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject to concentration of credit risk consist of cash and cash held in trust. Cash is comprised of cash balances with banks and bank deposits, which are insured by the Federal Deposit Insurance Company (“FDIC”), up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zNSVi8juLbn4">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company did not have cash exceed FDIC limits at June 30, 2024 and December 31, 2023. Cash held in trust is comprised of securities held by a financial institution, which are insured by the Securities Investor Protection Corporation (“SIPC”), comprised of $<span id="xdx_900_ecustom--CashSIPCInsuredAmount_iI_c20240630_zvn2BdxALfMa" title="Cash SIPC insured amount">250,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">coverage for cash and $<span id="xdx_901_eus-gaap--CashCollateralForBorrowedSecurities_iI_c20240630_zR2IryR9jFMi">250,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for securities. The Company had approximately $<span id="xdx_906_eus-gaap--SecuritiesReceivedAsCollateralAmountForeclosed_c20240101__20240630_zJCm28hIvmMc">14,338,710 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--SecuritiesReceivedAsCollateralAmountForeclosed_c20230101__20231231_zkLyz114cDfj">13,729,449 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of securities in excess of SIPC limits as of June 30, 2024 and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.4pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	DUET	Cash Sipc Insured Amount CashSIPCInsuredAmount	250000	usd
CY2024Q2	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	250000	usd
	us-gaap	Securities Received As Collateral Amount Foreclosed SecuritiesReceivedAsCollateralAmountForeclosed	14338710	usd
CY2023	us-gaap	Securities Received As Collateral Amount Foreclosed SecuritiesReceivedAsCollateralAmountForeclosed	13729449	usd
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	785497	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	785497	usd
CY2024Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2024Q2	DUET	Extension Loan ExtensionLoan	1370000	usd
CY2023Q4	DUET	Extension Loan ExtensionLoan	1090000	usd
CY2023Q2	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	30000	usd
CY2024Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	2330	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	60000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	60000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares

Files In Submission

Name	View Source	Status
0001493152-24-035069-index-headers.html	Edgar Link	pending
0001493152-24-035069-index.html	Edgar Link	pending
0001493152-24-035069.txt	Edgar Link	pending
0001493152-24-035069-xbrl.zip	Edgar Link	pending
duet-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
duet-20240630_cal.xml	Edgar Link	unprocessable
duet-20240630_pre.xml	Edgar Link	unprocessable
duet-20240630_lab.xml	Edgar Link	unprocessable
duet-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DUET
DUET Acquisition Corp Stock $duet

2024 Q2 Form 10-Q Financial Statement

#000149315224035069 Filed on September 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUET DUET Acquisition Corp Stock $duet

2024 Q2 Form 10-Q Financial Statement

#000149315224035069 Filed on September 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUET
DUET Acquisition Corp Stock $duet